Designing Organoid Models to Monitor Cancer Progression, Plasticity and Resistance: The Right Set Up for the Right Question.

Doffe, Flora; Bonini, Fabien; Lakis, Emile; Terry, Stéphane; Chouaib, Salem; Savagner, Pierre

Doffe, Flora; Bonini, Fabien; Lakis, Emile; Terry, Stéphane; Chouaib, Salem; Savagner, Pierre.

Afiliação

Doffe F; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France.
Bonini F; Department of Pathology and Immunology, Faculty of Medicine, University Geneva, 1205 Geneva, Switzerland.
Lakis E; LGC Standards, 67120 Molsheim, France.
Terry S; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France.
Chouaib S; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France.
Savagner P; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates.

Cancers (Basel) ; 14(15)2022 Jul 22.

Article em En | MEDLINE | ID: mdl-35892818

Palavras-chave

3D model; breast cancer; extracellular matrix; microfluidics; organoid; personalized medicine; plasticity; preclinical assay; resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google